TrialAmerican journal of respiratory and critical care medicine2026

Treatment with Allogeneic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multicenter Phase 2b Clinical Trial (STAT).

Michael A Matthay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.